arrow
T

Tal Sella

chaim sheba medical center
H指数:22
被引数:1,772

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

De-escalated chemotherapy and endocrine therapy outcomes in young women with stage I HR+/HER2+breast cancer: An international real-world study.

年轻女性中I期HR+/HER2+乳腺癌降级化疗和内分泌治疗效果:一项国际真实世界研究

2026-06-010
PRE
Outcomes and treatment patterns in germline BRCA1/2 carriers from two matched cohort

胚系BRCA1/2携带者两组匹配队列的研究结果与治疗模式

2026-05-250
OA
Adjuvant ovarian function suppression and aromatase inhibitors in premenopausal patients with hormone receptor and HER2 positive breast cancer, by timing of chemotherapy and trastuzumab and response to neoadjuvant therapy.

辅助性卵巢功能抑制和芳香化酶抑制剂在激素受体和HER2阳性乳腺癌绝经前患者中的应用,按化疗和曲妥珠单抗的时机及新辅助治疗的反应。

2025-12-060
OAAI
Fertility preservation and fertility treatment use in young breast cancer survivors reporting a live birth

乳腺癌幸存者生育力保存及生育治疗的使用情况报告:活产出生

2025-09-270
PRE
Safety of taxane chemotherapy for the treatment of breast cancer during pregnancy: an international cohort study
2024-05-020
PRE
Taxanes for the treatment of breast cancer during pregnancy: an international cohort study

紫杉烷类药物治疗妊娠期乳腺癌: 一项国际队列研究

2023-12-074
PRE
Conception and pregnancy among women with a live birth after breast cancer treatment: A survey study of young breast cancer survivors

乳腺癌治疗后活产妇女的受孕和妊娠: 年轻乳腺癌幸存者的调查研究

CANCER
IF5.1
2023-10-252
PRE
Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor-Positive Breast Cancer
2023-07-142
OAAI
Breastfeeding in Survivors of Early Breast Cancer
2023-03-010
PRE